Optimind Pharma Corp. (OMND.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 02/28
| 05-2024 | 02-2024 | 11-2023 | 08-2023 | 05-2023 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 0 | 0 | 5 | 7 | 7 |
| Income taxes - deferred | N/A | -9 | 0 | 0 | 0 |
| Accounts receivable | 108 | -6 | 8 | -23 | -22 |
| Accounts payable and accrued liabilities | N/A | 136 | 76 | -45 | -17 |
| Other Working Capital | 215 | 130 | 83 | -69 | -39 |
| Other Operating Activity | -206 | -255 | -179 | -86 | -173 |
| Operating Cash Flow | $117 | $-3 | $-7 | $-216 | $-244 |
| Cash Flows From Investing Activities | |||||
| Net Acquisitions | 0 | 23 | -16 | -3 | -4 |
| Other Investing Activity | 0 | -23 | 0 | 0 | 0 |
| Investing Cash Flow | $0 | $0 | $-16 | $-3 | $-4 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | 0 | 0 | -8 | -11 | -11 |
| Financing Cash Flow | $0 | $0 | $-8 | $-11 | $-11 |
| Beginning Cash Position | 29 | 32 | 63 | 293 | 552 |
| End Cash Position | 146 | 29 | 32 | 63 | 293 |
| Net Cash Flow | $117 | $-3 | $-31 | $-230 | $-259 |
| Free Cash Flow | |||||
| Operating Cash Flow | 117 | -3 | -7 | -216 | -244 |
| Free Cash Flow | 117 | -3 | -7 | -216 | -244 |